Cancer BiologyNature CommunicationsPeer-reviewed
WEE1 inhibitors synergise with mRNA translation defects via activation of the kinase GCN2
Jordan Wilson, Jiayi Zhu, Vanesa Vinciauskaite…·Stephen P. Jackson
This study shows WEE1 inhibitors work better with mRNA translation defects by activating GCN2, and suggests ways to reduce off-target effects.
3 citations